Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (7136)	3/5/1999 10:39:00 AM
From: Jim Lamb	Respond to of 9523

<<Pfizer and Monsanto haven't specified how Celebrex profits are split, but some Wall Street analysts have estimated that Monsanto will keep 55% to 60%.>> Nice find BigK.

To: BigKNY3 who wrote (7136)	3/5/1999 11:34:00 AM
From: Anthony Wong	Respond to of 9523

State Shrinks Get Lecture Tours on Drug Makers' Dime New York Post, March 5, 1999 nypostonline.com

To: BigKNY3 who wrote (7136)	3/5/1999 11:36:00 AM
From: Anthony Wong	Respond to of 9523

Money + Science = Ethics Problems on Campus The Nation, March 22, 1999 thenation.com

To: BigKNY3 who wrote (7136)	3/5/1999 12:14:00 PM
From: Bull-like	Read Replies (1) \| Respond to of 9523

BigK- If this profit-split number holds up, it's pretty generous for PFE, isn't it? At least, as a share-holder, I like this number. Da bull

To: BigKNY3 who wrote (7136)	3/5/1999 1:48:00 PM
From: Anthony Wong	Read Replies (2) \| Respond to of 9523

Reuters: Study Shows Viagra Does Not Work Well In Women Friday March 5 12:55 PM ET WASHINGTON (Reuters) - Viagra, Pfizer's blockbuster impotence drug that has transformed the sex lives of millions of men, does not work so well in women, a study published Friday finds. ''We found that there was no significant change either in intercourse satisfaction or in the degree of sexual desire after the patients had taken Viagra for 12 weeks,'' said Dr. Steven Kaplan, a urologist who heads the clinic at Columbia Presbyterian Center in New York where the study was conducted. ''Even though about 25 percent of the patients had some improvement in overall sexual function, that's equal to the placebo response in men receiving Viagra,'' Kaplan said. ''So that response might be a placebo effect rather than a true improvement in sexual function due to the drug.'' Kaplan's study, published in the journal Urology, is the first published study of Viagra in women, although several others are being conducted. Viagra, known generically as sildenafil, works by increasing the effects of nitric oxide, a common body chemical, which in turn gets more blood flowing into the genitals. Doctors have said theoretically it should work the same way for women -- helping sexual function once a person is aroused. Pfizer says seven million prescriptions have been written for Viagra worldwide, which earned the company $788 million last year. dailynews.yahoo.com